Dermatological care of the diabetic foot

American Journal of Clinical Dermatology

Volumn 3, Issue 7, 2002, Pages 463-474

  Aye, M ^a   Masson, E A ^a,b  

^a UNIVERSITY OF HULL   (United Kingdom)

^b HULL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOROLFINE; ANTIFUNGAL AGENT; CICLOPIROX; CICLOPIROXOLAMINE; CLOTRIMAZOLE; CORTICOSTEROID; ECONAZOLE; GRISEOFULVIN; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; ORAL ANTIDIABETIC AGENT; TERBINAFINE;

AUTONOMIC NEUROPATHY; COMORBIDITY; DIABETES MELLITUS; DIABETIC FOOT; DISEASE ASSOCIATION; DRY SKIN; ECZEMA; EDEMA; GRANULOMA ANNULARE; HUMAN; JOINT LIMITATION; NAIL INFECTION; NECROBIOSIS LIPOIDICA; PATCH TEST; PERIPHERAL NEUROPATHY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; REVIEW; SEPSIS; SKIN ALLERGY; SKIN DISEASE; SKIN INFECTION; SKIN ULCER; TISSUE INJURY; VENOUS RETURN;

EID: 0036038399     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200203070-00003     Document Type: Review

References (61)

1. Skin and connective tissue disorders in diabetes mellitus
2. Neuropathic problems of the lower extremities in diabetic patients
3. Non-enzymatic glycosylation of keratin from the stratum comeum of the diabetic foot
4. The association between callus formation, high pressures and neuropathy in diabetic foot ulceration
5. The biomechanics of foot in diabetes mellitus
6. Infection and diabetes mellitus
7. NIDDM and prevalence of nasal Staphylococcus aureus colonization: San Luis Valley Diabetes study
8. Staphylococcus aureus carriage and infections among patients in four haemo- and peritoneal-dialysis centres in Denmark: The Danish Study Group of Peritonitis in Dialysis (DASPID)
9. Infectious problems of the foot in diabetes
10. The prevalence of dermatophyte infection in well-controlled diabetics and the response to Trichophyton antigen
11. Prevalence of dermatophytosis in patients with diabetes
12. Fungal infection of the diabetic foot: Two distinct syndromes
13. Fungal infections in HIV-infected patients
14. Prevalence of foot problems and the need for foot care in an unselected diabetic population
15. Ciclopirox 8% nail lacquer in the treatment of onychomycosis of the toenails in the United States
16. A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region
17. Mechanism of action of antifungals and combination therapy
18. Contact sensitivity to topical antimicrobials, II: Sensitizing potentials of some topical antimicrobials
19. Drug-induced skin disease
20. Topical drugs
21. Clinical prediction of patch tests
22. The skin in diabetes
23. Cutaneous aspects of diabetes mellitus
24. Necrobiosis lipoidica diabeticorum, a clinical and pathological examination of 171 cases
25. The skin in diabetes mellitus
26. Focal endothelial cell degeneration and proliferative endarteritis in trauma-induced early lesions of necrobiosis lipoidica diabeticorum
27. Increased plasma fibronectin in diabetes mellitus, necrobiosis lipoidica and widespread granuloma annulare
28. The cutaneous immunopathology of necrobiosis lipoidica diabeticorum
29. Diffuse necrobiosis lipoidica diabeticorum associated with non-insulin dependent diabetes mellitus
30. Vascular reactivity during the first year of diabetes in children
31. Cutaneous aspects of diabetes mellitus
32. Squamous cell carcinoma developing in necrobiosis lipoidica
33. Carcinoma cuniculatum arising in necrobiosis lipoidica
34. Granuloma annulare and necrobiosis lipoidica treated by jet injector
35. Necrobiosis lipoidica: Treatment with systemic corticosteroids
36. The surgical treatment of necrobiosis lipoidica diabeticorum
37. Localised granuloma annulare is associated with insulin-dependent diabetes mellitus
38. Diabetic dermopathy and internal complications in diabetes mellitus
39. Pigmented pretibial patches, with special references to the clinical classification and the correlation to HbA1 which serves as an index of diabetic control
40. An atrophic circumscribed skin lesion in the lower extremities of diabetics
41. Diabetes short stature and joint stiffness: A new syndrome
42. Limited joint mobility in insulin dependent childhood diabetes
43. Limitation of joint mobility (cheiroarthropathy) in adult noninsulin-dependent diabetic patients
44. Limited joint mobility is associated with the presence but does not predict the development of microvascular complications in type 1 diabetes
45. Limited joint mobility and other rheumatological manifestations in diabetic patients
46. Limited joint mobility (LJM) of the hand in patients with diabetes mellitus: Relation to chronic complications
47. Relationship of limited joint mobility to abnormal foot pressures and diabetic foot ulceration
48. Limited joint mobility in the diabetic foot: Relationship to neuropathic ulceration
49. Limited joint mobility in diabetes mellitus of childhood: Natural history, and relationship to growth impairment
50. Limited joint mobility of the hand in type I diabetes mellitus
51. Limited joint mobility (LJM) in insulin dependent diabetes mellitus (IDDM): Relationship to glucose and zinc nutriture
52. Limited joint mobility in childhood diabetes mellitus indicates increased risk for microvascular disease
53. Limited joint mobility (LJM) of the hand in patients with diabetes mellitus: Relation to chronic complications
54. Pathways to diabetic limb amputation: Basis for prevention
55. Experience in a multidisciplinary diabetic foot clinic: The foot in diabetes
56. Lawrence lecture: The diabetic foot: Neuropathic in aetiology?
57. Efficacy of the dorsal pedal bypass for limb salvage in diabetic patients: Short-term observations
58. Mortality following amputation in diabetes
59. A team approach to diabetic foot care: The Manchester experience